MedTrace Logo

Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy

NCT04556435 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2023-11-18

No results posted yet for this study

Summary

The aim of this study is to sample and analyze volatile organic compounds (VOCs) from lung cancer patients and individuals without lung cancer ("healthy" controls). The breath sample analysis will help investigators describe and identify profiles of VOCs found in the breath of patients with lung cancer when compared to normal breath profiles using infrared spectroscopy. This work will help validate early proof of concept results conducted with prototype technology and later stage NSCLC breath samples, and inform future breath testing analysis.

Conditions

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • Breathe BioMedical Inc

    lead INDUSTRY

Principal Investigators

  • Ali Mahtabifard, MD · University of California, Irvine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-25
Primary Completion
2023-08-04
Completion
2023-08-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04556435 on ClinicalTrials.gov